Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug. The nation's largest ...

GSK will pay up to $2.2 billion to resolve 93% of U.S. Zantac cases. GSK expects to recognize a £1.8 billion ($2.3 billion) charge in Q3 2024 related to these settlements. Historic Summer Setup: 3 ...

Patients allege that heartburn drug caused their cancer Court says expert opinions not backed by reliable science FDA asked in 2020 that Zantac be pulled from market Patients' lawyer says scientific ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...

GSK GSK0.37%increase; green up pointing triangle agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters) - ...

Ohio Attorney General Dave Yost is pushing to lead a class-action lawsuit against a pharmaceutical company. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] He is accusing GSK, formerly ...

In a significant legal win for GSK plc (NYSE:GSK), on Friday, a Florida State Court ruled in favor of the pharmaceutical giant, excluding the plaintiff’s expert testimonies that claimed ranitidine, a ...

On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...

He is accusing GSK, formerly known as GlaxoSmithKline, of hiding the cancer risks of its once-popular heartburn drug, Zantac. Yost filed a motion on Monday requesting that the Ohio Public Employees ...